Stocks of the Hour: ImpediMed, Imugene, Brightstar Resources
ImpediMed (ASX:IPD) are the first top 5 national payor covering SOZO testing for cancer patients at risk for lymphoedema. In response, CEO and MD Richard Valencia said, ”Cigna’s policy provides access to coverage for all individuals at risk of developing limb lymphoedema without prior authorisation and impacts all 50 states.” Shares are trading 17.57 per […]
Stocks of the Hour: ImpediMed, Imugene, Brightstar Resources Read More »